HRT Financial’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,989
| Closed | -$3.49M | – | 4269 |
|
|
2025
Q4 | $3.1M | Sell |
14,989
-1,185,714
| -99% | -$234M | 0.01% | 1025 |
|
|
2025
Q3 | $223M | Buy |
1,200,703
+829,718
| +224% | +$142M | 0.82% | 10 |
|
|
2025
Q2 | $56.7M | Buy |
370,985
+302,304
| +440% | +$46.5M | 0.25% | 47 |
|
|
2025
Q1 | $11.4M | Sell |
68,681
-81,968
| -54% | -$12.8M | 0.07% | 212 |
|
|
2024
Q4 | $21.8M | Sell |
150,649
-8,125
| -5% | -$1.26M | 0.11% | 112 |
|
|
2024
Q3 | $25.7M | Buy |
158,774
+98,131
| +162% | +$15.6M | 0.13% | 89 |
|
|
2024
Q2 | $8.86M | Sell |
60,643
-33,092
| -35% | -$4.92M | 0.05% | 269 |
|
|
2024
Q1 | $14.8M | Buy |
+93,735
| New | +$14.9M | 0.09% | 106 |
|
|
2023
Q3 | – | Sell |
-165,025
| Closed | -$27.2M | – | 2748 |
|
|
2023
Q2 | $27.3M | Buy |
+165,025
| New | +$26.6M | 0.26% | 43 |
|
|
2022
Q4 | – | Sell |
-145,252
| Closed | -$23.7M | – | 2807 |
|
|
2022
Q3 | $23.7M | Buy |
+145,252
| New | +$24.6M | 0.26% | 59 |
|
|
2021
Q3 | – | Sell |
-127,325
| Closed | -$21.7M | – | 3515 |
|
|
2021
Q2 | $21M | Buy |
127,325
+87,081
| +216% | +$14.4M | 0.19% | 84 |
|
|
2021
Q1 | $6.61M | Buy |
+40,244
| New | +$6.51M | 0.07% | 214 |
|
|
2020
Q3 | – | Sell |
-103,436
| Closed | -$14.5M | – | 2129 |
|
|
2020
Q2 | $14.5M | Buy |
+103,436
| New | +$15.1M | 0.44% | 39 |
|
|
2019
Q3 | – | Sell |
-62,978
| Closed | -$8.77M | – | 1498 |
|
|
2019
Q2 | $8.77M | Buy |
62,978
+61,100
| +3,253% | +$8.46M | 0.55% | 38 |
|
|
2019
Q1 | $262K | Sell |
1,878
-6,792
| -78% | -$910K | 0.04% | 324 |
|
|
2018
Q4 | $1.12M | Buy |
8,670
+6,888
| +387% | +$961K | 0.16% | 105 |
|
|
2018
Q3 | $246K | Sell |
1,782
-2,875
| -62% | -$382K | 0.04% | 290 |
|
|
2018
Q2 | $565K | Sell |
4,657
-6,897
| -60% | -$860K | 0.21% | 87 |
|
|
2018
Q1 | $1.48M | Buy |
11,554
+202
| +2% | +$27.3K | 0.71% | 26 |
|
|
2017
Q4 | $1.59M | Buy |
+11,352
| New | +$1.58M | 1.62% | 5 |
|
|
2017
Q3 | – | Sell |
-1,880
| Closed | -$248K | – | 123 |
|
|
2017
Q2 | $248K | Sell |
1,880
-844
| -31% | -$108K | 0.39% | 36 |
|
|
2017
Q1 | $339K | Buy |
2,724
+864
| +46% | +$103K | 0.32% | 45 |
|
|
2016
Q4 | $214K | Hold |
1,860
| – | – | 0.27% | 55 |
|
|
2016
Q3 | $219K | Sell |
1,860
-469
| -20% | -$56.9K | 0.19% | 71 |
|
|
2016
Q2 | $282K | Buy |
2,329
+469
| +25% | +$53.3K | 0.17% | 71 |
|
|
2016
Q1 | $201K | Buy |
+1,860
| New | +$193K | 0.21% | 64 |
|
|
2015
Q1 | – | Sell |
-7,492
| Closed | -$783K | – | 81 |
|
|
2014
Q4 | $783K | Buy |
+7,492
| New | +$790K | 1.1% | 13 |
|
Other funds holding JNJ
VCM
VPM
HRT Financial's JNJ Position: Q1 2026 in Review
HRT Financial sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 14,989 shares — an estimated $3.49M sold.
HRT Financial first reported a position in JNJ in Q4 2014 and held it in 27 quarters. The position peaked at $223M in Q3 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- HRT Financial reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
- HRT Financial sold 14,989 Johnson & Johnson shares in Q1 2026, an estimated $3.49M.
- HRT Financial first reported a position in Johnson & Johnson in Q4 2014 and held it in 27 quarters.
- HRT Financial's Johnson & Johnson position peaked at $223M in Q3 2025.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.